Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("BARALIAKOS, X")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 25

  • Page / 1
Export

Selection :

  • and

Therapy of ankylosing spondylitis - : a review. Part I Conventional medical treatment and surgical therapyBRAUN, J; BARALIAKOS, X; GODOLIAS, G et al.Scandinavian journal of rheumatology. 2005, Vol 34, Num 2, pp 97-108, issn 0300-9742, 12 p.Article

Magnetic resonance imaging examinations of the spine in patients with ankylosing spondylitis before and after therapy with the tumor necrosis factor α receptor fusion protein etanerceptBARALIAKOS, X; DAVIS, J; TSUJI, W et al.Arthritis and rheumatism. 2005, Vol 52, Num 4, pp 1216-1223, issn 0004-3591, 8 p.Article

Decreased incidence of anterior uveitis in patients with ankylosing spondylitis treated with the anti-tumor necrosis factor agents infliximab and etanerceptBRAUN, J; BARALIAKOS, X; LISTING, J et al.Arthritis and rheumatism. 2005, Vol 52, Num 8, pp 2447-2451, issn 0004-3591, 5 p.Article

Perioperativer Umgang mit Biologika bei rheumatoider Arthritis : Elektive Rheumachirurgie aus Sicht des Rheumaorthopäden und internistischen Rheumatologen = Perioperative use of biologicals in rheumatoid arthritis : Elective rheumatological surgery from the perspective of rheumatoid orthopedists and internist rheumatologistsHELDMANN, F; DYBOWSKI, F; BARALIAKOS, X et al.Zeitschrift für Rheumatologie (Print). 2011, Vol 70, Num 1, issn 0340-1855, 14-20 [6 p.]Article

Therapy of ankylosing spondylitis. Part II. Biological therapies in the spondyloarthritidesBRAUN, J; BARALIAKOS, X; BRANDT, J et al.Scandinavian journal of rheumatology. 2005, Vol 34, Num 3, pp 178-190, issn 0300-9742, 13 p.Article

Development of a Radiographic Scoring Tool for Ankylosing Spondylitis Only Based on Bone Formation: Addition of the Thoracic Spine Improves Sensitivity to ChangeBARALIAKOS, X; LISTING, J; RUDWALEIT, M et al.Arthritis care and research. 2009, Vol 61, Num 6, pp 764-771, issn 0893-7524, 8 p.Article

A Comparison of New Bone Formation in Patients With Ankylosing Spondylitis and Patients With Diffuse Idiopathic Skeletal Hyperostosis: A Retrospective Cohort Study Over Six YearsBARALIAKOS, X; LISTING, J; BUSCHMANN, J et al.Arthritis and rheumatism. 2012, Vol 64, Num 4, pp 1127-1133, issn 0004-3591, 7 p.Article

Glucocorticoid treatment in spondyloarthritisFENDLER, C; BARALIAKOS, X; BRAUN, J et al.Clinical and experimental rheumatology (Testo stampato). 2011, Vol 29, Num 5, issn 0392-856X, S139-S142, SUP68Article

Progression of radiographic damage in patients with ankylosing spondylitis : defining the central role of syndesmophytesBARALIAKOS, X; LISTING, J; RUDWALEIT, M et al.Annals of the rheumatic diseases. 2007, Vol 66, Num 7, pp 910-915, issn 0003-4967, 6 p.Article

Radiographic progression in patients with ankylosing spondylitis after 4 yrs of treatment with the anti-TNF-α antibody infliximabBARALIAKOS, X; LISTING, J; BRANDT, J et al.Rheumatology (Oxford. Print). 2007, Vol 46, Num 9, pp 1450-1453, issn 1462-0324, 4 p.Article

Persistent reduction of spinal inflammation as assessed by magnetic resonance imaging in patients with ankylosing spondylitis after 2 yrs of treatment with the anti-tumour necrosis factor agent infliximabSIEPER, J; BARALIAKOS, X; LISTING, J et al.Rheumatology (Oxford. Print). 2005, Vol 44, Num 12, pp 1525-1530, issn 1462-0324, 6 p.Article

Magnetic resonance imaging examinations of the spine in patients with Ankylosing spondylitis, before and after successful therapy with infliximab: Evaluation of a new scoring systemBRAUN, J; BARALIAKOS, X; GOLDER, W et al.Arthritis and rheumatism. 2003, Vol 48, Num 4, pp 1126-1136, issn 0004-3591, 11 p.Article

The Assessment of SpondyloArthritis international Society (ASAS) handbook: a guide to assess spondyloarthritisSIEPER, J; RUDWALEIT, M; VAN DER HEIJDE, D et al.Annals of the rheumatic diseases. 2009, Vol 68, issn 0003-4967, ii1-ii44, SUP2Article

Differences in the incidence of flares or new onset of inflammatory bowel diseases in patients with ankylosing spondylitis exposed to therapy with anti-tumor necrosis factor α agentsBRAUN, J; BARALIAKOS, X; LISTING, J et al.Arthritis care and research. 2007, Vol 57, Num 4, pp 639-647, issn 0893-7524, 9 p.Article

Persistent clinical efficacy and safety of anti-tumour necrosis factor α therapy with infliximab in patients with ankylosing spondylitis over 5 years : evidence for different types of responseBRAUN, J; BARALIAKOS, X; ZEIDLER, H et al.Annals of the rheumatic diseases. 2008, Vol 67, Num 3, pp 340-345, issn 0003-4967, 6 p.Article

Assessment of acute spinal inflammation in patients with ankylosing spondylitis by magnetic resonance imaging : a comparison between contrast enhanced T1 and short tau inversion recovery (STIR) sequencesBARALIAKOS, X; HERMANN, K.-G. A; BRAUN, J et al.Annals of the rheumatic diseases. 2005, Vol 64, Num 8, pp 1141-1144, issn 0003-4967, 4 p.Article

Outcome of patients with active ankylosing spondylitis after two years of therapy with etanercept : Clinical and magnetic resonance imaging dataBARALIAKOS, X; BRANDT, J; LISTING, J et al.Arthritis care and research. 2005, Vol 53, Num 6, pp 856-863, issn 0893-7524, 8 p.Article

The degree of spinal inflammation is similar in patients with axial spondyloarthritis who report high or low levels of disease activity: a cohort studyKILTZ, U; BARALIAKOS, X; BRAUN, J et al.Annals of the rheumatic diseases. 2012, Vol 71, Num 7, pp 1207-1211, issn 0003-4967, 5 p.Article

Persistent clinical response to the anti-TNF-α antibody infliximab in patients with ankylosing spondylitis over 3 yearsBRAUN, J; BARALIAKOS, X; SÖRENSEN, H et al.Rheumatology (Oxford. Print). 2005, Vol 44, Num 5, pp 670-676, issn 1462-0324, 7 p.Article

Analysing chronic spinal changes in ankylosing spondylitis: a systematic comparison of conventional x rays with magnetic resonance imaging using established an new scoring systemsBRAUN, J; BARALIAKOS, X; VAN DER HEIJDE, D et al.Annals of the rheumatic diseases. 2004, Vol 63, Num 9, pp 1046-1055, issn 0003-4967, 10 p.Article

2010 update of the ASAS/EULAR recommendations for the management of ankylosing spondylitisBRAUN, J; VAN DEN BERG, R; GEHER, P et al.Annals of the rheumatic diseases. 2011, Vol 70, Num 6, pp 896-904, issn 0003-4967, 9 p.Article

Defining active sacroiliitis on magnetic resonance imaging (MRI) for classification of axial spondyloarthritis: a consensual approach by the ASAS/OMERACT MRI groupRUDWALEIT, M; JURIK, A. G; HERMANN, K-G. a et al.Annals of the rheumatic diseases. 2009, Vol 68, Num 10, pp 1520-1527, issn 0003-4967, 8 p.Article

Efficacy of sulfasalazine in patients with inflammatory back pain due to undifferentiated spondyloarthritis and early ankylosing spondylitis : a multicentre randomised controlled trialBRAUN, J; ZOCHLING, J; MIELKE, F et al.Annals of the rheumatic diseases. 2006, Vol 65, Num 9, pp 1147-1153, issn 0003-4967, 7 p.Article

Inflammation in ankylosing spondylitis : a systematic description of the extent and frequency of acute spinal changes using magnetic resonance imagingBARALIAKOS, X; LANDEWE, R; BRAUN, J et al.Annals of the rheumatic diseases. 2005, Vol 64, Num 5, pp 730-734, issn 0003-4967, 5 p.Article

Magnetic resonance imaging of the spine and the sacroiliac joints in ankylosing spondylitis and undifferentiated spondyloarthritis during treatment with etanerceptRUDWALEIT, M; BARALIAKOS, X; LISTING, J et al.Annals of the rheumatic diseases. 2005, Vol 64, Num 9, pp 1305-1310, issn 0003-4967, 6 p.Article

  • Page / 1